1315 Capital Acquires miraDry Business from Sientra
June 11, 2021
1315 Capital, a healthcare growth equity firm, has acquired the miraDry business from Sientra, enabling Sientra to focus on its core Breast Products business. The transaction transfers ownership of the miraDry FDA-cleared sweat-reduction device and related business to 1315 Capital, which plans to invest in service, support, training and global expansion.
- Buyers
- 1315 Capital
- Targets
- miraDry
- Sellers
- Sientra, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
1315 Capital Acquires Biocoat, Inc.
January 16, 2019
Medical Devices
Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.
-
1315 Capital Provides Growth Financing to ProSciento
September 10, 2020
Healthcare Services
ProSciento, a San Diego–based specialty clinical research organization focused on NASH, diabetes and obesity, closed a growth financing round with healthcare investor 1315 Capital. The capital will support expansion of ProSciento's CRO operations and growth of its patient access solutions, including the NASH PASS registry.
-
iCapital to Acquire Mirador
April 2, 2024
Financial Services
iCapital and Mirador announced a definitive agreement under which iCapital will acquire Mirador. The acquisition is intended to expand iCapital’s data management and financial reporting capabilities for wealth management, family office, endowment, and foundation clients.
-
Citrus Health Group and NaviMed Capital Acquire Mirador Global, LLC
September 9, 2024
Healthcare Services
Citrus Health Group, together with investor NaviMed Capital, acquired Mirador Global, LLC, a Kennett Square–based commercialization and market access consulting firm. The deal brings Mirador’s launch planning, market access, and commercial strategy expertise into Citrus’s service offering; founder Chuck Peipher will join Citrus’s executive leadership as Chief Strategy Officer while remaining CEO of Mirador Global.
-
1315 Capital Acquires SciSafe from BioLife Solutions
November 14, 2024
Healthcare Services
1315 Capital, a Philadelphia-based growth equity firm, has acquired SciSafe from BioLife Solutions in an all-cash transaction that establishes SciSafe as an independent, standalone biostorage company. The deal accompanies a growth capital investment to fund expansion of SciSafe's biostorage, cold-chain and compliance capabilities and to support global footprint growth.
-
1315 Capital Invests in Triple Ring Technologies
February 1, 2024
Healthcare Services
1315 Capital, a Philadelphia-based healthcare growth equity firm, made a growth capital investment in Triple Ring Technologies, a Silicon Valley-based medical device and life sciences co-development and engineering services company. The investment will accelerate Triple Ring's geographic expansion and extension of its R&D and product development services to scale its engineering and outsourced R&D services platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.